Epilex Chrono 200 Tablet CR Eazy Glide is a controlled-release antiepileptic formulation containing Sodium Valproate (135 mg) and Valproic Acid (58 mg), designed to provide sustained therapeutic plasma concentrations for effective seizure management. This combination is indicated for the treatment of various types of epilepsy, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. The controlled-release mechanism ensures a gradual release of active ingredients, enhancing patient compliance by reducing dosing frequency and minimizing peak-related side effects. Sodium Valproate and Valproic Acid act primarily by increasing gamma-aminobutyric acid (GABA) levels in the brain, thereby stabilizing neuronal membranes and preventing abnormal electrical discharges. Epilex Chrono 200 is also utilized as a mood stabilizer in bipolar disorder and for prophylaxis of migraine headaches. It should be administered under medical supervision with regular monitoring of liver function, blood counts, and plasma drug levels to avoid potential adverse effects such as hepatotoxicity, thrombocytopenia, and teratogenicity. Dose adjustments may be necessary in patients with hepatic impairment or concomitant use of other antiepileptic drugs. Patients are advised to adhere strictly to prescribed dosages and report any unusual symptoms promptly to their healthcare provider.